Skip to main content

Table 2 Characteristics of included patients stratified by LHR tertiles

From: Association between the low-density lipoprotein to high-density lipoprotein ratio and prognosis in critically ill intracerebral hemorrhage patients: a retrospective cohort study from the MIMIC-IV database

Variables

Total (n = 873)

T1 (n = 287)

T2 (n = 293)

T3 (n = 293)

p-value

LHR

1.7 (1.2, 2.4)

1.0 (0.8, 1.2)

1.7 (1.6, 1.9)

2.8 (2.4, 3.4)

< 0.001

Demographic variables

 Age, years

71 (60, 81)

75 (65, 83)

74 (61, 82)

65 (54, 75)

< 0.001

 Weight, kg

77.8 (64.5, 93)

71.2 (59.8, 84)

77.8 (63.8, 93)

84 (72, 99.3)

< 0.001

 Male

472 (54.1)

135 (47)

161 (54.9)

176 (60.1)

0.007

 Ethnicity (White)

482 (55.2)

167 (58.2)

167 (57)

148 (50.5)

0.134

Clinical severity

 GCS

12 (8, 14)

12 (8, 14)

12 (9, 14)

13 (9, 14)

0.29

 SOFA

4 (2, 6)

4 (3, 6)

4 (2, 6)

4 (2, 6)

0.142

 SAPS-II

31 (24, 39)

33 (26, 39)

33 (26, 40)

28 (21, 36)

< 0.001

 OASIS

32 (26, 38)

33 (27.5, 39)

33 (27, 38)

31 (25, 36)

< 0.001

Comorbidities

 IVH

131 (15.0)

49 (17.1)

44 (15)

38 (13)

0.384

 Hypertension

158 (18.1)

48 (16.7)

62 (21.2)

48 (16.4)

0.246

 Diabetes

250 (28.6)

71 (24.7)

96 (32.8)

83 (28.3)

0.101

 COPD

94 (10.8)

37 (12.9)

28 (9.6)

29 (9.9)

0.363

 Myocardial infarct

92 (10.5)

32 (11.1)

26 (8.9)

34 (11.6)

0.515

 CHF

143 (16.4)

59 (20.6)

43 (14.7)

41 (14)

0.064

 PVD

54 (6.2)

16 (5.6)

21 (7.2)

17 (5.8)

0.689

 Renal failure

125 (14.3)

38 (13.2)

46 (15.7)

41 (14)

0.686

 Hepatic disorders

10 (1.1)

1 (0.3)

5 (1.7)

4 (1.4)

0.357

 Sepsis

292 (33.4)

104 (36.2)

86 (29.4)

102 (34.8)

0.178

Laboratory tests

 WBC, 109/L

9.0 (7.1, 11.4)

8.7 (6.8, 11.2)

8.6 (7.0, 11.0)

9.2 (7.5, 11.8)

0.041

 Hb, g/L

12.2 ± 1.9

11.8 ± 1.9

12.1 ± 1.9

12.7 ± 1.9

< 0.001

 Hematocrit, vol%

37.0 ± 5.5

35.8 ± 5.4

36.6 ± 5.4

38.5 ± 5.4

< 0.001

 Platelets, 109/L

201 (161, 250)

183 (150, 238.5)

201 (162, 243)

211 (174, 259)

< 0.001

 Glucose, mg/dL

139.8 ± 61.2

137.7 ± 53.5

139.7 ± 66.7

142.0 ± 62.7

0.7

 Sodium, mmol/L

138.2 ± 4.0

137.8 ± 4.0

138.4 ± 4.0

138.5 ± 4.0

0.049

 Potassium, mmol/L

3.8 (3.5, 4.1)

3.8 (3.5, 4.1)

3.8 (3.5, 4.1)

3.8 (3.5, 4.1)

0.834

 Serum creatinine, mg/dL

0.9 (0.7, 1.1)

0.8 (0.6, 1.0)

0.8 (0.7, 1.0)

0.9 (0.7, 1.1)

0.003

 Urea nitrogen, mg/dL

15 (11, 20)

15 (11, 20)

15 (11, 20)

15 (11, 21)

0.909

 PT, s

12.2 (11.3, 13.2)

12.2 (11.3, 13.3)

12.1 (11.3, 13.1)

12.2 (11.4, 13.1)

0.631

 APTT, s

27.3 (24.8, 30.0)

27.4 (25.2, 30.2)

27.1 (24.3, 29.8)

27.3 (24.9, 30.1)

0.501

Treatments

 Cerebral surgery

94 (10.8)

28 (9.8)

28 (9.6)

38 (13)

0.328

 Mechanical ventilation

352 (40.3)

130 (45.3)

116 (39.6)

106 (36.2)

0.078

 Statins

307 (35.4)

86 (30.4)

101 (34.6)

120 (41.1)

0.026

 Vasopressor

225 (25.8)

94 (32.8)

73 (24.9)

58 (19.8)

0.002

  1. LHR low-density lipoprotein to high-density lipoprotein ratio, GCS Glasgow Coma Scale, SOFA Sequential Organ Failure Assessment, SAPS-II Simplified Acute Physiology Score II, OASIS Oxford Acute Severity of Illness Score, IVH intraventricular hemorrhage, COPD chronic obstructive pulmonary disease, CHF congestive heart failure, PVD Peripheral vascular disease, WBC white blood cell count, PT prothrombin time, APTT activated partial